Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Serono Rebif: 80% Of Rxs Are Switches, Efficacy Is Main Marketing Message

Dec 09 2002

• By The Pink Sheet

Related Content

Serono/Pfizer Rebif Will Reach 30% Share By 2006, Serono Says

Jul 29 2002

Serono Rebif Approval Is First Orphan Drug Challenge Based On Efficacy

Mar 11 2002

Serono Rebif 25% Market Share Expected By 2006; Monthly Price Is $1,156

Mar 18 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window